Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
American Water Works
AWK
$27.1B
| $5.59M | ﹤0.01% |
45,000
-109,200
| -71% | -$13.2M |
|
1727
Navient
NAVI
$860M
| $5.59M | ﹤0.01% |
+436,500
| New | +$5.82M |
|
1728
CareDx
CDNA
$2.34B
| $5.58M | ﹤0.01% |
247,000
-85,800
| -26% | -$2.38M |
|
|
DBD
1729
DELISTED
Diebold Nixdorf Incorporated
DBD
| $5.58M | ﹤0.01% |
497,807
+428,107
| +614% | +$5.07M |
|
1730
Hooker Furnishings Corp
HOFT
$158M
| $5.56M | ﹤0.01% |
259,500
+22,400
| +9% | +$450K |
|
|
SPNE
1731
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.56M | ﹤0.01% |
455,100
+38,100
| +9% | +$460K |
|
1732
Minerva Neurosciences
NERV
$219M
| $5.55M | ﹤0.01% |
89,525
+7,500
| +9% | +$425K |
|
1733
MacroGenics
MGNX
$268M
| $5.54M | ﹤0.01% |
434,353
+9,930
| +2% | +$143K |
|
1734
Performance Food Group
PFGC
$16.8B
| $5.54M | ﹤0.01% |
+120,300
| New | +$5.35M |
|
1735
Global Industrial
GIC
$1.48B
| $5.51M | ﹤0.01% |
250,500
+78,600
| +46% | +$1.64M |
|
1736
Cato Corp
CATO
$67.9M
| $5.51M | ﹤0.01% |
312,643
+116,093
| +59% | +$1.74M |
|
|
CSTR
1737
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $5.49M | ﹤0.01% |
331,367
+192,795
| +139% | +$3M |
|
1738
Arbor Realty Trust
ABR
$950M
| $5.47M | ﹤0.01% |
+417,440
| New | +$5.21M |
|
1739
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $5.47M | ﹤0.01% |
89,800
-75,100
| -46% | -$4.57M |
|
|
AY
1740
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $5.47M | ﹤0.01% |
226,940
+188,340
| +488% | +$4.44M |
|
|
GDEN
1741
DELISTED
Golden Entertainment
GDEN
| $5.46M | ﹤0.01% |
410,861
+163,161
| +66% | +$2.27M |
|
1742
Information Services Group
III
$250M
| $5.44M | ﹤0.01% |
2,187,354
-19,893
| -0.9% | -$53.4K |
|
1743
EnerSys
ENS
$7.42B
| $5.43M | ﹤0.01% |
+82,400
| New | +$5.17M |
|
|
ALTA
1744
DELISTED
Altabancorp
ALTA
| $5.42M | ﹤0.01% |
191,400
+30,500
| +19% | +$866K |
|
|
NPTN
1745
DELISTED
NEOPHOTONICS CORP
NPTN
| $5.41M | ﹤0.01% |
888,811
+853,153
| +2,393% | +$4.79M |
|
1746
Eastern Company
EML
$153M
| $5.41M | ﹤0.01% |
217,810
+4,310
| +2% | +$108K |
|
1747
Sonida Senior Living
SNDA
$1.88B
| $5.41M | ﹤0.01% |
82,275
+14,028
| +21% | +$981K |
|
|
CMRX
1748
DELISTED
Chimerix, Inc.
CMRX
| $5.4M | ﹤0.01% |
2,299,627
+539,458
| +31% | +$1.56M |
|
1749
Walker & Dunlop
WD
$1.46B
| $5.4M | ﹤0.01% |
96,500
-80,100
| -45% | -$4.5M |
|
1750
Varex Imaging
VREX
$779M
| $5.39M | ﹤0.01% |
188,900
+122,800
| +186% | +$3.55M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.